GSK3B and early-onset autosomal dominant Alzheimer disease: In the context of Alzheimer’s disease (AD), GSK3-β has drawn extensive attention due to its involvement in the phosphorylation of tau protein, a key player in the development of neurofibrillary tangles, one of the hallmark pathological features of AD2.